Strata continues to work closely with CMS to ensure a rapid implementation of the extended codesHORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today affirms its patent portfolio provides intellectual property (IP) and market exclusivity for combination therapies of its XTRAC excimer lase ...